Spherix Litigation Against Cisco Continues On Patents Acquired from Rockstar Consortium
BETHESDA, Md., Nov.
Purdue Pharma L.P. Receives FDA Approval for HysinglaTM ER (hydrocodone bitartrate) Extended-Release Tablets CII, A Once-Daily Opioid Analgesic Formulated with Abuse-Deterrent Properties
IMS Health Study Forecasts Global Spending on Medicines to Increase 30 Percent by 2018, to $1.3 Trillion
Global Oncology Market to hit $109 billion - Spotlight on Drug Life Cycle Management, M&A and Pipeline Strategies
LONDON and NEW YORK, November 19, 2014 /PRNewswire/ --
First Long-Acting Treatment to be Used Four Times a Year for Schizophrenia in Adults
TITUSVILLE, N.J., Nov.
Two new, large scale real-world analyses show fewer major bleeds and strokes with Pradaxa® than with warfarin
New data show dabigatran-specific antidote idarucizumab* restores blood clotting mechanism in humans
Amgen Presents Long-Term Data Showing Efficacy And Safety Of Investigational Cholesterol-Lowering Medication Evolocumab Across Lipid And LDL-C Levels
Additional Data Analysis Showed Every Two Week and Monthly Dosing Regimens of Evolocumab Were Clinically Equivalent
THOUSAND OAKS, Calif.